Short answer
Cigna (CI) filed its Q1 2026 10-Q quarterly report on Apr 30, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $68.5B (up 4.6% year over year) with net income of $1.7B.
Q1 2026 key financials · XBRL
- Revenue
- $68.5B
- +4.6% YoY
- Net income
- $1.7B
- +25.0% YoY
- Operating margin
- 3.4%
- EPS (diluted)
- $6.26
- +29.1% YoY
Source: XBRL data from the Cigna (CI) Q1 2026 10-Q on SEC EDGAR. USD.
Cigna Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Period covered: three months ended March 31, 2026
- Financial condition comparison: March 31, 2026 vs December 31, 2025
- Results comparison: March 31, 2026 vs same period last year
Risk Factors
- No risk-factors section provided; submitted text covers equity purchases, insider trading, exhibits, and signatures
- CEO 10b5-1 plan adopted February 6, 2026, covering up to 212,543 vested stock options
- Performance-award share sales subject to outcomes ranging from 0% to 200% of 62,366 target shares
- Repurchase authorization permits up to $6,730 million of additional purchases, subject to market conditions
- Trading plan extends through April 30, 2027, under Rule 10b5-1(c) safety provisions
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Cigna quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.